Development and Characterization of Pectinate Micro/Nanoparticles for Gene Delivery
暂无分享,去创建一个
Theerasak Rojanarata | Praneet Opanasopit | Tanasait Ngawhirunpat | P. Opanasopit | T. Ngawhirunpat | T. Rojanarata | U. Ruktanonchai | Uracha Ruktanonchai | Auayporn Apirakaramwong | A. Apirakaramwong
[1] H. D. Liggitt,et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery , 1997, Nature Biotechnology.
[2] G. Hardee,et al. Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carriers. , 2002, International journal of pharmaceutics.
[3] Sydney Brenner,et al. The End of the Beginning , 2000, Science.
[4] V. Pillay,et al. In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. II. Physicochemical characterization of calcium-alginate, calcium-pectinate and calcium-alginate-pectinate pellets. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[5] M. Norgard,et al. Factors affecting the transformation of Escherichia coli strain chi1776 by pBR322 plasmid DNA. , 1978, Gene.
[6] E. Fattal,et al. In vitro and in vivo evaluation of pectin beads for the colon delivery of β-lactamases , 2005 .
[7] Lonnie D Shea,et al. Controlled release systems for DNA delivery. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] J C Barbenel,et al. Novel Quantitative Methods for the Determination of Biomaterial Cytotoxicity , 1992, The International journal of artificial organs.
[9] A. Maitra,et al. DNA encapsulated magnesium and manganous phosphate nanoparticles: potential non-viral vectors for gene delivery. , 2005, Biomaterials.
[10] S. Segawa,et al. End of the beginning , 1990, Nature.
[11] B. Ruozi,et al. Cationic Liposomes for Gene Transfection , 2003, Journal of drug targeting.
[12] J. Hagstrom,et al. pH-sensitive, cationic liposomes: A new synthetic virus-like vector , 1996, Nature Biotechnology.
[13] Munia Ganguli,et al. PEI-alginate nanocomposites as efficient in vitro gene transfection agents. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[14] A. Mikos,et al. Poly(ethylenimine) and its role in gene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[15] F. Atyabi,et al. Bovine Serum Albumin–Loaded Pectinate Beads as Colonic Peptide Delivery System: Preparation and In Vitro Characterization , 2005, Drug delivery.
[16] A. Maitra,et al. pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery. , 2005, International journal of pharmaceutics.
[17] M. Alonso,et al. PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[18] A. El-Aneed,et al. An overview of current delivery systems in cancer gene therapy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[19] Shubiao Zhang,et al. Cationic compounds used in lipoplexes and polyplexes for gene delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[20] K. Cheng,et al. Insulin‐Loaded Calcium Pectinate Nanoparticles: Effects of Pectin Molecular Weight and Formulation pH , 2004, Drug development and industrial pharmacy.
[21] M. Garnett,et al. Gene-delivery systems using cationic polymers. , 1999, Critical reviews in therapeutic drug carrier systems.
[22] V. Pillay,et al. In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. I. Comparison of pH-responsive drug release and associated kinetics. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[23] R. Reusch,et al. Genetic competence in Escherichia coli requires poly-beta-hydroxybutyrate/calcium polyphosphate membrane complexes and certain divalent cations , 1995, Journal of bacteriology.
[24] E. Fattal,et al. Evaluation of critical formulation parameters influencing the bioactivity of beta-lactamases entrapped in pectin beads. , 2006, International journal of pharmaceutics.
[25] F. Alexis,et al. Low molecular weight polyethylenimines linked by β‐cyclodextrin for gene transfer into the nervous system , 2006, The journal of gene medicine.
[26] P. Sriamornsak,et al. Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins from calcium pectinate gel beads. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[27] A. Rolland. Gene medicines: the end of the beginning? , 2005, Advanced drug delivery reviews.
[28] R. Miller,et al. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Pérez,et al. Molecular basis of C(2+)-induced gelation in alginates and pectins: the egg-box model revisited. , 2001, Biomacromolecules.
[30] A. Göpferich,et al. Polyethylenimine-based non-viral gene delivery systems. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.